BD Showcases Next-Generation Drug Delivery and RFID Traceability Solutions at CPhI 2025

 BD (Becton, Dickinson and Company), a leading medical technology company, will feature the next generation of drug delivery and traceability s...

October 28, 2025 | Tuesday | News
Neurotronic Presents First Clinical Results of Neuviant™ Multi-Organ Denervation in Type 2 Diabetes and Hypertension at TCT 2025

Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease, announced that the first clinical outcom...

October 28, 2025 | Tuesday | News
Thermo Fisher Scientific Showcases Next-Generation Biopharma Solutions and AI-Driven Innovations at CPHI Frankfurt 2025

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo ...

October 28, 2025 | Tuesday | News
Xencor Reports Promising Phase 1 Results for XmAb819 in Advanced Clear Cell Renal Cell Carcinoma

-- XmAb819 is well-tolerated in heavily pretreated patients with advanced ccRCC -- -- 25% overall response rate (ORR) observed within the target dose ...

October 27, 2025 | Monday | News
Xencor to Present Initial Phase 1 Data for XmAb819 Bispecific Antibody in Renal Cell Carcinoma at AACR-NCI-EORTC Conference

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, announced the...

October 15, 2025 | Wednesday | News
Daiichi Sankyo Showcases Transformative ADC Data at ESMO 2025

Back-to-back Presidential Symposium presentations of ENHERTU from DESTINY-Breast11 and DESTINY-Breast05 demonstrate its potential to become a foundat...

October 14, 2025 | Tuesday | News
AstraZeneca at ESMO 2025: Advancing Oncology Across Breast, Bladder, Gastric, Lung, and Prostate Cancers

Presidential Symposium will feature DESTINY-Breast11 and DESTINY-Breast05, underscoring potential of ENHERTU® (fam-trastuzumab deruxtecan-nxki) in ...

October 14, 2025 | Tuesday | News
ABLi Therapeutics Announces Positive Phase 2 Results for Risvodetinib in Untreated Parkinson’s Disease

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosin...

October 10, 2025 | Friday | News
Philips Unveils Next-Generation CT and Helium-Free MR Systems to Transform Precision and Sustainability in Radiation Therapy

New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value Philips deb...

September 29, 2025 | Monday | News
Johnson & Johnson’s RYBREVANT® Plus LAZCLUZE® Demonstrates Superior Resistance Prevention Over Osimertinib in EGFR-Mutated Lung Cancer

Johnson & Johnson announced new analyses from the Phase 3 MARIPOSA study demonstrating that first-line treatment with RYBREVANT® (amivantamab-vmj...

September 08, 2025 | Monday | News
BIO 2025 Closes in Boston with Global Biotech Leaders Uniting for a New Era of Innovation and Impact

The BIO International Convention 2025 concluded in Boston with an exceptional display of biopharmaceutical innovation, regulatory dialogue, investment di...

June 20, 2025 | Friday | News
PharmaJet and Immuno Cure Partner to Advance Needle-Free HIV Therapeutic DNA Vaccine with Tropis® ID System

Agreement builds on PharmaJet’s strategy to be the best-in-class delivery system for novel DNA- and RNA-based vaccines and immunotherapies usin...

June 20, 2025 | Friday | News
BIO 2025 Day 2 Roundup: Innovation, Partnerships, and Global Momentum Define the Convention

Transformative Science and Global Health Solutions The convention floor buzzed with activity as Azitra, Inc. confirmed its pivotal presentation on novel...

June 18, 2025 | Wednesday | News
Ecolab Unveils Purolite AP+50 Resin to Enhance Cost-Efficiency and Performance in Antibody Manufacturing at BIO 2025

Ecolab Life Sciences announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manuf...

June 17, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close